Tech Company Inital Public Offerings
Neos Therapeutics IPO
On 7/23/2015, Neos Therapeutics became a public company.
Transaction Overview
Company Name
Announced On
7/23/2015
Transaction Type
IPO
Amount
$72,000,000
Proceeds Purpose
The principal purposes of this offering are to increase our financial flexibility, create a public market for our common stock and facilitate our access to public equity markets. We currently intend to use the net proceeds that we will receive from this offering for as follows: approximately $12.1 million for pre-commercialization planning of our three lead product candidates, NT-0102, NT-0202 and NT-0201; approximately $28.7 million for commercialization of our three lead product candidates, if approved; and the remainder for working capital, capital expenditures and general corporate purposes, including investing further in research and development efforts.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2940 N Hwy. 360 400
Grand Prairie, TX 75050
USA
Grand Prairie, TX 75050
USA
Phone
Website
Email Address
Overview
Neos Therapeutics (NASDAQ: NEOS) is a specialty pharmaceutical company that focuses on time-release technologies. We have developed a broad, cutting-edge portfolio of processes that allow for tailored and independent release profiles of single and multiple ingredients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jerry McLaughlin
Chief Financial Officer
Richard Eisenstadt
VP - General Counsel
John Limongelli
VP - Human Resources
Sarah Foster
VP - Operations
Margaret Cabano
VP - R & D
Russ McMahen
Browse more venture capital transactions:
Prev: 7/23/2015: VoltDB venture capital transaction
Next: 7/23/2015: Ra Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs